Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Jan 8, 2020

30198_dirs_2020-01-07_2a6cd64a-40ae-402b-b9b6-da6f694deb16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-01-03

Reporting Person: FOLETTA MARK G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-03 Common Stock S 528 $217.612 Disposed 15619 Indirect
2020-01-03 Common Stock S 339 $218.3933 Disposed 15280 Indirect
2020-01-03 Common Stock S 133 $218.9355 Disposed 15147 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3055 Direct

Footnotes

F1: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $216.79
to $217.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

F4: This transaction was executed in multiple trades at prices ranging from $217.80 to $218.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $218.86 to $219.06. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.